-
1
-
-
78650106014
-
The epidemiology of urinary tract infections
-
Foxman B. The epidemiology of urinary tract infections. Nature Rev Urol 2010;7:653-60
-
(2010)
Nature Rev Urol
, vol.7
, pp. 653-660
-
-
Foxman, B.1
-
2
-
-
79952199427
-
Management of complicated urinary tract infections in the era of antimicrobial resistance
-
Bader MS, Hawboldt J, Brooks A. Management of complicated urinary tract infections in the era of antimicrobial resistance. Postgrad Med 2010;122:7-15
-
(2010)
Postgrad Med
, vol.122
, pp. 7-15
-
-
Bader, M.S.1
Hawboldt, J.2
Brooks, A.3
-
3
-
-
36448971944
-
Complicated urinary tract infections
-
Neal Jr DE. Complicated urinary tract infections. Urol Clin N Am 2008;35:13-22
-
(2008)
Urol Clin N Am
, vol.35
, pp. 13-22
-
-
Neal Jr., D.E.1
-
4
-
-
33746766906
-
Urinary-catheter-associated infections in the elderly
-
Kunin CM. Urinary-catheter-associated infections in the elderly. Int J Antimicrob Agents 2006;28(Suppl 1):S78-81
-
(2006)
Int J Antimicrob Agents
, vol.28
, Issue.SUPPL. 1
-
-
Kunin, C.M.1
-
5
-
-
70149090868
-
A multinational survey of risk factors for infection with extended-spectrum jß-lactamase-producing Enterobacteriaceae in nonhospitalized patients
-
Ben-Ami R, Rodríguz-Bano J, Arslan H, et al. A multinational survey of risk factors for infection with extended-spectrum jß-lactamase- producing Enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 2009;49:682-90
-
(2009)
Clin Infect Dis
, vol.49
, pp. 682-690
-
-
Ben-Ami, R.1
Rodríguz-Bano, J.2
Arslan, H.3
-
6
-
-
77249104101
-
Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: Changing epidemiology and drug treatment choices
-
Pitout JD. Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 2010;70:313-33
-
(2010)
Drugs
, vol.70
, pp. 313-333
-
-
Pitout, J.D.1
-
7
-
-
62749195559
-
The real threat of Klebsiella pneumoniae carbapenemase producing bacteria
-
Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase producing bacteria. Lancet Infect Dis 2009;9:228-36
-
(2009)
Lancet Infect Dis
, vol.9
, pp. 228-236
-
-
Nordmann, P.1
Cuzon, G.2
Naas, T.3
-
8
-
-
79952420498
-
Current concepts in antimicrobial therapy against resistant Gram-negative organisms: Extended-spectrum jß-lactamase-produ-cing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa
-
Kanj SS, Kanafani ZA. Current concepts in antimicrobial therapy against resistant Gram-negative organisms: Extended-spectrum jß-lactamase-produ- cing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa. Mayo Clin Proc 2011; 86:250-9
-
(2011)
Mayo Clin Proc
, vol.86
, pp. 250-259
-
-
Kanj, S.S.1
Kanafani, Z.A.2
-
9
-
-
77955560486
-
Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens
-
Pfeifer Y, CullikA, Witte W. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens. Int J Med Microbiol 2010;300:371-9
-
(2010)
Int J Med Microbiol
, vol.300
, pp. 371-379
-
-
Pfeifer, Y.1
Cullik, A.2
Witte, W.3
-
10
-
-
79957581336
-
Status report on carbapenemases: Challenge and prospects
-
Patel G, Bonomo RA. Status report on carbapenemases: challenge and prospects. Expert Rev Anti Infect Ther 2011;9:555-70
-
(2011)
Expert Rev Anti Infect Ther
, vol.9
, pp. 555-570
-
-
Patel, G.1
Bonomo, R.A.2
-
11
-
-
78650883759
-
Emergence of Klebsiella pneumonia carbapenemase-producing bacteria
-
Arnold RS, Thom KA, Sharma S, et al. Emergence of Klebsiella pneumonia carbapenemase-producing bacteria. South Med J 2011;104:40-5
-
(2011)
South Med J
, vol.104
, pp. 40-45
-
-
Arnold, R.S.1
Thom, K.A.2
Sharma, S.3
-
13
-
-
54549112247
-
NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases
-
Livermore DM, Mushtaq S, Warner M, et al. NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases. J Antimicrob Chemother 2008;62:1053-6
-
(2008)
J Antimicrob Chemother
, vol.62
, pp. 1053-1056
-
-
Livermore, D.M.1
Mushtaq, S.2
Warner, M.3
-
14
-
-
67749143907
-
In vitro activity of NXL104 in combination with beta-lactams against Klebsiella pneumoniae isolates producing KPC carbapenemases
-
Endimiani A, Choudhary Y, Bonomo RA. In vitro activity of NXL104 in combination with beta-lactams against Klebsiella pneumoniae isolates producing KPC carbapenemases. Antimicrob Agents Chemother 2009;53:3599-601
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 3599-3601
-
-
Endimiani, A.1
Choudhary, Y.2
Bonomo, R.A.3
-
15
-
-
67650718178
-
In vitro activity of the beta-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases
-
Stachyra T, Levasseur P, Péchereau MC, et al. In vitro activity of the beta-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases. J Antimicrob Chemother 2009;64:326-9
-
(2009)
J Antimicrob Chemother
, vol.64
, pp. 326-329
-
-
Stachyra, T.1
Levasseur, P.2
Péchereau, M.C.3
-
16
-
-
79955537450
-
Activity of NXL104 in combination with beta-lactams against genetically characterized Escherichia coli and Klebsiella pneumoniae isolates producing class A extended-spectrum beta-lactamases and class C beta-lactamases
-
Lagacé-Weins PR, Tailor F, Simner P, et al. Activity of NXL104 in combination with beta-lactams against genetically characterized Escherichia coli and Klebsiella pneumoniae isolates producing class A extended-spectrum beta-lactamases and class C beta-lactamases. Antimicrob Agents Chemother 2011;55:2434-7
-
(2011)
Antimicrob Agents Chemother
, vol.55
, pp. 2434-2437
-
-
Lagacé-Weins, P.R.1
Tailor, F.2
Simner, P.3
-
17
-
-
78650636489
-
Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-producing Enterobacteriaceae
-
Livermore DM, Mushtaq S, Warner M, et al. Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-producing Enterobacteriaceae. Antimicrob Agents Chemother 2011;55:390-4
-
(2011)
Antimicrob Agents Chemother
, vol.55
, pp. 390-394
-
-
Livermore, D.M.1
Mushtaq, S.2
Warner, M.3
-
19
-
-
33646696219
-
-
Clinical and Laboratory Standards Institute Twentieth informational supplement. M100-S20, Wayne, PA, USA
-
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; Twentieth informational supplement. M100-S20, Wayne, PA, USA, 2010
-
(2010)
Performance Standards for Antimicrobial Susceptibility Testing
-
-
-
20
-
-
84856228220
-
Epidemiology, treatment and prevention of healthcare-associated urinary tract infections
-
Wagenlehner FME, Cek M, Naber KG, et al. Epidemiology, treatment and prevention of healthcare-associated urinary tract infections. World J Urol 2012;30:59-67
-
(2012)
World J Urol
, vol.30
, pp. 59-67
-
-
Wagenlehner, F.M.E.1
Cek, M.2
Naber, K.G.3
-
21
-
-
70349134718
-
Intravenous doripenem at 500 milligrams versus levofloxacin at 250 milligrams, with an option to switch to oral therapy, for treatment of complicated lower urinary tract infection and pyelonephritis
-
Naber KG, Llorens L, Kaniga K, et al. Intravenous doripenem at 500 milligrams versus levofloxacin at 250 milligrams, with an option to switch to oral therapy, for treatment of complicated lower urinary tract infection and pyelonephritis. Antimicrob Agents Chemother 2009;53:3782-92
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 3782-3792
-
-
Naber, K.G.1
Llorens, L.2
Kaniga, K.3
-
22
-
-
23244454191
-
Double-blind, controlled study to evaluate safety and efficacy of doripenem and meropenem in patients with complicated urinary tract infection
-
[Article in Japanese.] Jpn
-
Kamidono S, Arakawa S, Hirose T, et al. [Double-blind, controlled study to evaluate safety and efficacy of doripenem and meropenem in patients with complicated urinary tract infection.] [Article in Japanese.] Jpn J Chemother 2005;53(Suppl 1):244-59
-
(2005)
J Chemother
, vol.53
, Issue.SUPPL. 1
, pp. 244-259
-
-
Kamidono, S.1
Arakawa, S.2
Hirose, T.3
-
23
-
-
0028589111
-
Piperacillin/tazobactam in complicated urinary tract infections
-
Nowé P. Piperacillin/tazobactam in complicated urinary tract infections. Intensive Care Med 1994;20(Suppl 3):S39-42
-
(1994)
Intensive Care Med
, vol.20
, Issue.SUPPL. 3
-
-
Nowé, P.1
-
24
-
-
0029872212
-
Piperacillin/tazobactam in the treatment of hospitalized patients with urinary tract infections: An open non-comparative and multicentered trial
-
Sifuentes-Osornio J, Jakob E, Clara L, et al. Piperacillin/tazobactam in the treatment of hospitalized patients with urinary tract infections: an open non-comparative and multicentered trial. J Chemother 1996;8:122-9
-
(1996)
J Chemother
, vol.8
, pp. 122-129
-
-
Sifuentes-Osornio, J.1
Jakob, E.2
Clara, L.3
-
25
-
-
0026768843
-
Imipenem/cilastatin. A reappraisal of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy
-
Buckley MM, Brogden RN, Barradell LB, et al. Imipenem/cilastatin. A reappraisal of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1992;44:408-44
-
(1992)
Drugs
, vol.44
, pp. 408-444
-
-
Buckley, M.M.1
Brogden, R.N.2
Barradell, L.B.3
-
26
-
-
0036583850
-
Effectiveness of Imipenemcilastatin (Tienam MSD) in Treating Complicated Infections in Urology
-
[Russian.] May-June
-
Derevianko II, Nefedova LA, Lavrinova LN. [Effectiveness of imipenem/cilastatin (Tienam, MSD) in treating complicated infections in urology.] [Russian.] Urologiia 2002 May-June;(3):21-5
-
(2002)
Urologiia
, Issue.3
, pp. 21-25
-
-
Derevianko, I.I.1
Nefedova, L.A.2
Lavrinova, L.N.3
-
27
-
-
0029031384
-
The renal membrane dipeptidase (dehydropepetidase I) inhibitor, cilastatin, inhibits the bacterial metallo-6-lactamase enzyme CphA
-
Keynan S, Hooper NM, Felici A, et al. The renal membrane dipeptidase (dehydropepetidase I) inhibitor, cilastatin, inhibits the bacterial metallo-6-lactamase enzyme CphA. Antimicrob Agents Chemother 1995;39:1629-31
-
(1995)
Antimicrob Agents Chemother
, vol.39
, pp. 1629-1631
-
-
Keynan, S.1
Hooper, N.M.2
Felici, A.3
|